Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study.
about
Short-term administration of growth hormone (GH) lowers blood pressure by activating eNOS/nitric oxide (NO)-pathway in male hypophysectomized (Hx) rats.GH and the cardiovascular system: an update on a topic at heartRegulation of inducible nitric oxide synthase activity/expression in rat hearts from ghrelin-treated ratsGrowth hormone exerts acute vascular effects independent of systemic or muscle insulin-like growth factor IGrowth hormone and the heart.Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?The GH/IGF-1 Axis and Heart Failure.Hormonal modulation of endothelial NO production.Extracellular water and blood pressure in adults with growth hormone (GH) deficiency: a genotype-phenotype association study.Hypopituitarism and atherosclerosis.Pre-weaning growth hormone treatment reverses hypertension and endothelial dysfunction in adult male offspring of mothers undernourished during pregnancy.Both low and high serum IGF-1 levels associate with increased risk of cardiovascular events in elderly menGrowth hormone deficiency and vascular risk.Role of Growth Hormone Deficiency and Treatment in Chronic Kidney DiseaseCurrent and future trends in the oral pharmacotherapy of male erectile dysfunction.The prolactin family hormones regulate vascular tone through NO and prostacyclin production in isolated rat aortic ringsGrowth hormone in anti-aging medicine: a critical review.Endocrine changes in critical illness.Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study.Adult growth hormone deficiency: to treat or not to treat.The future of the oral pharmacotherapy of male erectile dysfunction: things to come.Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice.Non-invasive measurement of the haemodynamic effects of inhaled salbutamol, intravenous L-arginine and sublingual nitroglycerin.Growth hormone, prolactin, and sexuality.Pituitary disease mortality: is it fiction?The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy.L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship.Effects of GH on lipid peroxidation and neutrophil superoxide anion-generating capacity in hypopituitary adults with GH deficiency.Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency.The IGF-1 receptor as a therapeutic target to improve endothelial progenitor cell function.Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study.Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects.Determination of oxidative protein and lipid damage in adult hypopituitary patients with GH deficiency.Platelet cGMP inversely correlates with age in healthy subjects.Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age.Reduced nitric oxide levels in acromegaly: cardiovascular implications.Blood asymmetric dimethylarginine and nitrite/nitrate concentrations in short-stature children born small for gestational age with and without growth hormone therapy.Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
P2860
Q24811861-85F38F7D-D677-4CAF-8B8E-A39E3D550F62Q27002329-1DB42D88-505F-40C1-966D-DBD524D82996Q28575518-B1FF62B5-BF8E-45AB-A801-733661AE72A7Q30439933-7F3A5536-35B4-4F80-BC1D-BFF9A8ED9DB8Q32026861-7204789E-B753-45EA-8D8C-5F2729CADCC1Q33569163-2DF911A6-F431-468E-BBBC-6A309E80716FQ33654009-02950D5C-2D2F-40E0-A8DE-FF79762966D6Q33833608-73956E8F-4BA5-4F56-93EF-FF415D479E3CQ34090179-FFC46F69-41B7-4F5A-9A10-D18DD8798A7DQ34420018-405E3844-4ADE-4521-A19E-BE978207515EQ34545145-59306AA5-1B59-4004-84A7-BDB5E9A4242DQ34647846-6DF1C5F3-89B9-423C-8852-3BD3EBDDCB3AQ34722657-FA4B4B61-1AEA-4D0E-8C3A-F8C7CBC50D67Q35149805-8D640D2A-8512-46D8-8862-ACB26395E8F1Q35207625-9DB1EE96-F2EB-4031-AF22-A4955D72E83AQ35578519-7A988680-DC33-4C3F-886C-EBE4AB5EA207Q35684580-6921798D-AA08-491F-8493-5492BA717845Q35740551-B33C04AA-943D-4EB9-ABEE-83F054828223Q36732731-2005AFFD-3E53-4F7D-B749-9B931ED90E2AQ36787300-2765B5C2-A0C1-427A-8D4E-C570443DF2DAQ36866594-E8F9A161-B394-496C-8014-4EF5BE4797B1Q37038972-F2CB9FCC-D303-4029-A5E5-5325028848EEQ37321403-AF0155EF-C7F9-450F-A321-372F671290E3Q38046711-437FBCB9-9985-4103-8F87-E3193380A992Q38080771-8088F924-7510-4A06-B395-AD242AA7BBC7Q38097351-273A644C-5445-46B7-92BC-7C13A8C791E3Q40986521-7210F46D-5AB6-40D7-8E56-1104BDBAAA0EQ42126268-DF2C34B1-90E0-4EBD-942D-38618621D3CAQ42520402-BAB2AEC1-C6A4-43FE-9DA0-3C5A7B170ACCQ42632946-878C9C50-BD13-4F3D-B837-697FD3DB1378Q42674748-6460D902-FDA6-4640-BE57-84B2DD463920Q43090694-201864FA-5629-4C9D-B6E8-645BD30702E8Q43967285-C8996B7F-730E-4DF9-86A4-390C6479FCF7Q44435391-0142446F-42A4-433B-BFB6-0FBD9762ED0FQ44753276-DA9C848F-9343-41A1-97BB-87A1A124A9C4Q44885635-1F9205F3-F3E7-4E59-80A1-F4123FBF847BQ46631268-BE3F741A-61A6-437E-873E-C9E3831717A2Q46673414-EBE93B26-1D6B-497E-992A-C238194E05E3Q48250482-91BC7775-B1B6-4BA6-AC17-AA11A7326C24Q49075956-F89AA4BF-367A-452B-BA4C-1FAE3B910120
P2860
Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nitric oxide may mediate the h ...... ind, placebo-controlled study.
@en
Nitric oxide may mediate the h ...... ind, placebo-controlled study.
@nl
type
label
Nitric oxide may mediate the h ...... ind, placebo-controlled study.
@en
Nitric oxide may mediate the h ...... ind, placebo-controlled study.
@nl
prefLabel
Nitric oxide may mediate the h ...... ind, placebo-controlled study.
@en
Nitric oxide may mediate the h ...... ind, placebo-controlled study.
@nl
P2093
P2860
P921
P356
P1476
Nitric oxide may mediate the h ...... ind, placebo-controlled study.
@en
P2093
Bode-Böger SM
Frolich JC
von zur Muhlen A
P2860
P304
P356
10.1172/JCI119095
P407
P577
1996-12-01T00:00:00Z